← SynDRA
GLICLAZIDE
SynDRA canonical compound SYN0006219 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ABCC8 |
|---|
| Mechanism of action | Insulin secretagogue |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
- ABCC8
- KCNJ11
- ABCC9
- AKR1C3
Mechanisms of action (all sources)
- ATP channel blocker
- Insulin secretagogue
- KCNJ11 BLOCKER
- Sulfonylurea receptor 1, Kir6.2 blocker
- ABCC8 BLOCKER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCC2
- FYN
- NPY1R
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KDM4A
- KCNH2
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH2
- HRH1
- HMGCR
- HDAC6
- GLS
- NPY2R
- NR1I2
- NR3C1
- SAMHD1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- diabezidum
- diabrezide
- diabyl
- diaprel
- glimicron
- glinormax
- glyzide
- gliclazid
- dizalid
- S 1702
- Gliclazida
- Glimicron
- J3.151H
- NSC-758673
- S-1702
- S-852
- SE-1702
- Bilxona
- Dacadis mr
- Diaglyk
- Diamicron
- Diamicron mr
- Edicil
- Glimil
- Nazdol mr
- Vamju
- Vitile xl
- Ziclaseg
- Zicron
- Zicron pr
- Diaikron
- Gliclazidum
- Gliklazid
- Glyclazide
- Nordialex
- SE 1702
- Diamicron (TN)
- Dianorm (TN)
Look up GLICLAZIDE in the interactive SynDRA portal →